Efficacy and Safety of Mosunetuzumab in Relapsed/Refractory Non-Hodgkin Lymphoma: A Systematic Review
Shatha Elemian(New York Medical College), Hamid Shaaban(Saint Michael's Medical Center), Gunwant Guron(New York Medical College), Bader Al Omour(Saint Michael's Medical Center), Jia Yi Tan(APLA Health), Samer Jumean(New York Medical College), Mohammad Hamad(MedStar Washington Hospital Center), Ahmad Habbas(New York Medical College), Kok Hoe Chan(Queen Mary Hospital)
Cited by 2
Related Papers
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
|Nature Genetics|2014|1.1k
How have US colorectal cancer mortality trends changed in the past 20 years?
|International Journal of Cancer|2024|21
Automated Classification and Analysis of Non-metallic Inclusion Data Sets
|Metallurgical and Materials Transactions B|2018|11
Social Vulnerability and Sickle Cell Disease Mortality in the US
|JAMA Network Open|2024|9